Hepatoid adenocarcinoma of the stomach: A report of three cases

被引:25
作者
Ye, Min-Feng [1 ]
Tao, Feng [1 ]
Liu, Fang [2 ]
Sun, Ai-Jing [2 ]
机构
[1] Zhejiang Univ, Shaoxing Hosp, Shaoxing Peoples Hosp, Dept Gastrointestinal Surg, Shaoxing 312000, Zhejiang, Peoples R China
[2] Zhejiang Univ, Shaoxing Hosp, Shaoxing Peoples Hosp, Dept Pathol, Shaoxing 312000, Zhejiang, Peoples R China
关键词
Hepatic adenocarcinoma; Gastric cancer; Alpha fetoprotein; Prognosis; Stomach; CLINICOPATHOLOGICAL CHARACTERISTICS; HEPATOCELLULAR-CARCINOMA; ALPHA-FETOPROTEIN; FEATURES;
D O I
10.3748/wjg.v19.i27.4437
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatoid adenocarcinoma of the stomach (HAS) is a rare form of gastric cancer that has unique clinicopathological features and an extremely poor prognosis. Here, we report on three patients with suspected gastric cancer who were referred to our hospital. Gastrointestinal fiberscopy on the three patients revealed two lesions in the antrum and a third lesion in the gastroesophageal junction. The alpha fetoprotein (AFP) serum levels were markedly elevated in all cases. At the time of diagnosis, two cases were advanced stages with lymph nodes and/or liver metastases. Two patients underwent exploratory laparotomy. A total gastrectomy was performed on the operable lesion, and an expanded gastrectomy was completed in the case with hepatic metastases. Histopathological analysis revealed that the tumors displayed two pathological changes: hepatoid-like foci and adenocarcinomatous. Furthermore, the tumor cells were immunohistochemically positive for AFP, alpha-1 antitrypsin, and alpha-1 antichymotrypsin. All three patients received chemotherapy. The follow-up duration ranged from 8-36 mo. Our experience and previous published studies have suggested that HAS is an aggressive type of adenocarcinoma. However, radical surgery and chemotherapy may positively impact clinical outcomes. (c) 2013 Baishideng. All rights reserved.
引用
收藏
页码:4437 / 4442
页数:6
相关论文
共 27 条
  • [1] Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer
    Baek, Sun Kyung
    Han, Sae-Won
    Oh, Do-Youn
    Im, Seock-Ah
    Kim, Tae-You
    Bang, Yung-Jue
    [J]. BMC GASTROENTEROLOGY, 2011, 11
  • [2] BOURREILLE J, 1970, PRESSE MED, V78, P1277
  • [3] Galvez-Munoz Elisa, 2009, Int Semin Surg Oncol, V6, P13, DOI 10.1186/1477-7800-6-13
  • [4] Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma
    Gao, Ya Bo
    Zhang, Ding Fang
    Jin, Xiao Long
    Xiao, Jia Cheng
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2007, 8 (01) : 23 - 28
  • [5] GARDINER GW, 1992, HISTOPATHOLOGY, V20, P541
  • [6] Hepatoid adenocarcinoma of the stomach
    Inagawa S.
    Shimazaki J.
    Hori M.
    Yoshimi F.
    Adachi S.
    Kawamoto T.
    Fukao K.
    Itabashi M.
    [J]. Gastric Cancer, 2001, 4 (1) : 43 - 52
  • [7] Gastrointestinal hepatoid adenocarcinoma: Venous permeation and mimicry of hepatocellular carcinoma, a report of four cases
    Ishikura, H
    Kishimoto, T
    Andachi, H
    Kakuta, Y
    Yoshiki, T
    [J]. HISTOPATHOLOGY, 1997, 31 (01) : 47 - 54
  • [8] ISHIKURA H, 1985, CANCER-AM CANCER SOC, V56, P840, DOI 10.1002/1097-0142(19850815)56:4<840::AID-CNCR2820560423>3.0.CO
  • [9] 2-E
  • [10] ISHIKURA H, 1986, CANCER-AM CANCER SOC, V58, P119, DOI 10.1002/1097-0142(19860701)58:1<119::AID-CNCR2820580121>3.0.CO